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Abstract
This study evaluated the effect of the synthetic, nonsteroidal antiestrogen drug tamoxifen on the function of brain mitochondria.
We observed that tamoxifen concentrations above 30 nmol/mg protein induced a slight decrease on RCR and ADP/O ratio.
However, only higher concentrations of tamoxifen (R 70 nmol/mg protein) affected the phosphorylative capacity of mitochondria.
Those effects were characterized by a decrease on mitochondrial transmembrane potential (DJm) and repolarization level and an
increase on repolarization lag phase with a decrease in ATP levels. Moreover, our results also show that tamoxifen presented
a potent capacity to inhibit hydrogen peroxide formation and reduced the extent of lipid peroxidation induced by the pro-oxidant
pair ADP/Fe2C. Tamoxifen also exerted some protection against mitochondrial permeability transition pore (MPT) opening,
although in a smaller extension than that promoted by cyclosporin A, the specific inhibitor of the MPT. However, in the presence of
tamoxifen plus cyclosporin A, the protection observed was significantly higher when compared with that induced by both agents
alone. Furthermore, tamoxifen avoided the oxidation of thiol groups and GSH depletion promoted by Ca2C.
These results show that tamoxifen can afford protection against brain mitochondrial injury promoted by several oxidative stress-
related events such as hydrogen peroxide production, lipid peroxidation and the induction of the MPT. Since numerous
neurodegenerative diseases are intimately related with mitochondrial dysfunction, future therapeutical strategies could be designed
taking into account this protective role of tamoxifen.
 2004 Elsevier Ltd. All rights reserved.
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The synthetic nonsteroidal antiestrogen drug tamox-
ifen (TAM) is widely used in the chemotherapy of breast
cancer (Richardson, 1988) and has been proposed as
a prophylactic agent against this disease. In humans,
TAM is extensively metabolised to give 4-hydroxyta-
moxifen (OHTAM) and N-desmethyltamoxifen (From-
son et al., 1973). Besides their chemopreventing
function, TAM and OHTAM, which are extremely
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cellular effects, including antioxidant actions since they
are strong intramembranous scavengers of peroxyl
radicals (Custo´dio et al., 1994).
Tamoxifen can penetrate the blood–brain barrier and
interact with several neuronal estrogen receptor-positive
cell populations (Jordan et al., 1983). Mehta et al. (2003)
observed that TAM dramatically reduced middle
cerebral artery occlusion-induced ischemic damage of
the affected cerebral hemisphere. The reduction of
infarct size was primarily due to protection of two
major structures, the cerebral cortex and striatum. In the
same study, Laser Doppler analysis revealed that
tamoxifen had no significant effect on cerebral blood
flow either before or after ischemia, suggesting that
tamoxifen protection is independent of cerebral blood
flow changes. More recently tamoxifen has been shown
to be markedly neuroprotective in rat models of
reversible and permanent focal ischemia (Kimelberg
et al., 2003; Feng et al., 2004). O’Neill and Brinton
(2002) showed that both TAM and OHTAM attenuate
the excitotoxic glutamate-induced intracellular Ca2C
rise. Furthermore, TAM suppresses the HOc generation
via dopamine efflux induced by MPPC (Obata, 2002). A
recent study shows that OHTAM attenuates metham-
phetamine-induced nigrostriatal dopaminergic toxicity
in intact and gonadetomized mice (Kuo et al., 2003).
However, the mechanisms of TAM-mediated neuro-
protection independently of estrogen receptors are not
yet clarified.
Recently, it has become clear that mitochondria have
a significant role to play not only in energy production,
but also in cell death (Bossy-Wetzel and Green, 1999). A
potentially central factor in cell death during neuro-
degeneration is the mitochondrial permeability transi-
tion pore (MPT) (Kim et al., 1999). The MPT is
a phenomenon that is characterized by the opening of
pores in the inner mitochondrial membrane and by its
sensitivity to a very low concentration of cyclosporin A
(CsA). Ca2C and oxidative stress have long been known
to favour the permeability transition (Zoratti and Szabo,
1995). The MPT possesses at least two redox-sensitive
sites that increase the probability of opening after
oxidation: (1) the ‘‘S-site’’, a dithiol in apparent redox
equilibrium with matrix glutathione and (2) the ‘‘P-site’’,
in apparent redox equilibrium with the pyridine nucleo-
tides pool (Chernyak and Bernardi, 1996).
Previous studies indicate that TAM (Custo´dio et al.,
1998) and OHTAM (Cardoso et al., 2002a) are potent
inhibitors of the MPT in liver mitochondria. Hoyt et al.
(2000) reported that TAM might be an inhibitor of the
MPT in intact neurons. However, MPT phenomenon in
intact neurons has proven difficult to establish since
other cellular components may contribute to misinter-
pretations, such as calcineurin that is also inhibited by
cyclosporin A (CsA), the specific inhibitor of MPT.With these evidences, we decided to study the effect of
TAM directly in isolated brain mitochondria. Our first
task was the evaluation of the impact of increasing
concentrations of TAM (15, 30, 70, 100 nmol/mg
protein) on the respiratory chain and oxidative system.
For that purpose we analysed the respiratory indexes
(RCR and ADP/O), mitochondrial transmembrane
potential (DJm), repolarization level, repolarization
lag phase and ATP levels. The second part of this study
consisted in the evaluation of the protective effect of
TAM against hydrogen peroxide production, lipid
peroxidation and Ca2C-induced MPT. The lipid perox-
idation was evaluated by analysing DJm, TBARS
formation and oxygen consumption while the induction
of MPT was characterized by analysing the DJm,
calcium fluxes, GSH content and protein thiol groups
oxidation.
2. Materials and methods
2.1. Materials
Tamoxifen and Protease type VIII (Subtilisin Carls-
berg) were obtained from Sigma Chemical Co. (St.
Louis, MO). Digitonin was obtained from Calbiochem
(Merck Biosciences Ltd., Nottingham). All the other
chemicals were of the highest grade of purity commer-
cially available.
2.2. Animals
Male Wistar rats (3 months old) were housed in our
animal colony (Laboratory Research Center, University
Hospital, Coimbra, Portugal). They were maintained
under controlled light (12 h day/night cycle) and humidity
with free access to water (except in the fasting period) and
powdered rodent chow (URF1-Charles River, France).
Adhering to procedures approved by the Institutional
Animal Care and Use Committee, the animals were
sacrificed by cervical displacement and decapitation.
2.3. Isolation of brain mitochondria
Brain mitochondria were isolated from male Wistar
by the method of Rosenthal et al. (1987), with slight
modifications, using 0.02% digitonin to free mitochon-
dria from the synaptosomal fraction. In brief, one rat is
decapitated, and the whole brain minus the cerebellum
was rapidly removed, washed, minced, and homoge-
nised at 4 C in 10 ml of isolation medium (225 mM
mannitol, 75 mM sucrose, 5 mM Hepes, 1 mM EGTA,
1 mg/ml bovine serum albumin, pH 7.4) containing 5 mg
of the bacterial protease. Single brain homogenates were
brought to 30 ml and then centrifuged at 2500 rpm
(Sorvall RC-5B Refrigerated Superspeed Centrifuge) for
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tant by centrifugation at 10,000 rpm for 8 min. The
pellet, including the fluffy synaptosomal layer, was
resuspended in 10 ml of the isolation medium containing
0.02% digitonin and centrifuged at 10,000 rpm for
8 min. The brown mitochondrial pellet without the
synaptosomal layer was then resuspended again in 10 ml
of medium and recentrifuged at 10,000 rpm for 10 min.
The mitochondrial pellet was resuspended in 300 ml of
resuspension medium (225 mM mannitol, 75 mM su-
crose, 5 mM Hepes, pH 7.4). Mitochondrial protein was
determined by the biuret method calibrated with bovine
serum albumin (Gornall et al., 1949).
2.4. Mitochondrial respiration measurements
Oxygen consumption of isolated mitochondria was
monitored polarographically with a Clark oxygen
electrode (Estabrook, 1967) connected to a suitable
recorder in a 1 ml thermostated water-jacketed closed
chamber with magnetic stirring. The reactions were
carried out at 30 C in 1 ml of the reaction medium
(100 mM sucrose, 100 mM KCl, 2 mM KH2PO4, 5 mM
Hepes, 10 mM EGTA, 2 mM rotenone, pH 7.4) with
0.6 mg protein. The isolates were incubated with TAM
for 2 min before succinate addition.
2.5. Membrane potential (DJm) measurements
The mitochondrial transmembrane potential was
monitored by evaluating the transmembrane distribu-
tion of TPPC (tetraphenylphosphonium) with a TPPC-
selective electrode prepared according to Kamo et al.
(1979) using an Ag/AgCl2 electrode as reference.
Reactions were carried out in a chamber with
magnetic stirring in 1 ml of reaction medium supple-
mented with 3 mM TPPC. The experiments were started
by adding 5 mM succinate to mitochondria in suspen-
sion at 0.6 mg protein/ml. Membrane potential was
estimated from the decrease of TPPC concentration in
the reaction medium as described elsewhere (Moreno
and Madeira, 1991). The isolates were incubated with
TAM for 2 min before succinate addition. In the MPT
experiments, after a steady-state distribution of TPPC
had been reached (ca. 2 min of recording), Ca2C was
added and DJm recorded. In the lipid peroxidation
experiments, 100 mM ADP/10 mM Fe2C were added
1 min after mitochondria energization.
2.6. Analysis of ATP levels
At the end of the DJm experiments, 250 ml of each
mitochondrial suspension were rapidly centrifuged at
14,000 rpm (Eppendorf Centrifuge 5415C) for 4 min
with 0.3 M perchloric acid. The supernatants were
neutralised with 10 M KOH in 5 M Tris and centrifugedat 14,000 rpm (Eppendorf Centrifuge 5415C) for 4 min.
The resulting supernatants were assayed for ATP by
separation in a reverse-phase high performance liquid
chromatography. The chromatography apparatus was
a Beckman-System Gold, consisting of a 126 Binary
Pump Model and 166 Variable UV detector controlled
by a computer. The detection wavelength was 254 nm,
and the column was a Lichrospher 100 RP-18 (5 mm)
from Merck. An isocratic elution with 100 mM phos-
phate buffer (KH2PO4) pH 6.5 and 1.0% methanol was
performed with a flow rate of 1 ml/min. The required
time for each analysis was 6 min.
2.7. Hydrogen peroxide production
Hydrogen peroxide (H2O2) production was measured
fluorimetrically using a modification of the method
described by Barja (1999). Briefly, mitochondria were
incubated at 30 C with 10 mM succinate in 2 ml of
phosphate buffer, pH 7.4, containing 0.1 mM EGTA,
5 mM KH2PO4, 3 mM MgCl2, 145 mM KCl, 30 mM
Hepes, 0.1 mM homovalinic acid and 6 U/ml horserad-
ish peroxidase. The incubation was stopped at 15 min
with 0.5 ml of cold 2 M glycine buffer containing 25 mM
EDTA and NaOH, pH 12. The fluorescence of super-
natants was measured at 312 nm as excitation and
420 nm as emission wavelengths. The peroxide pro-
duction was calculated using a standard curve of H2O2.
2.8. Lipid peroxidation
The extent of lipid peroxidation was evaluated by
oxygen consumption using a Clark-type electrode (YSI
Model 5331, Yellow Springs Inst.) in a closed glass
chamber equipped with magnetic stirring, thermostated
at 30 C, as described by Dinis et al. (1994). Reactions
were started by the addition of 100 mM ADP/10 mM
Fe2C. The changes in O2 tension were recorded in
a potentiometric chart recorder and the oxygen con-
sumption calculated assuming an oxygen concentration
of 236 nmol O2/ml. TAM was introduced in the
incubation medium, containing mitochondria, 2 min
before the addition of ADP/Fe2C.
Lipid peroxidation was also determined by measuring
thiobarbituric acid reactive substances (TBARS), using
the thiobarbituric acid assay (TBA), according to
a modified procedure described by Ernster and Norden-
brand (1967). The amount of TBARS formed was
calculated using a molar coefficient of 1.56!
105 mol1 cm1 and expressed as nmol TBARS/mg
protein.
2.9. Mitochondrial calcium fluxes
Mitochondrial calcium fluxes were measured by
monitoring the changes in Ca2C concentration in the
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according to previously described procedures (Moreno
and Madeira, 1991). The reactions were conducted in an
open vessel with magnetic stirring in 1 ml of the reaction
medium. Mitochondria (0.8 mg/ml) were energized with
5 mM succinate after 1 min of Ca2C addition. 30 nmol
TAM/mg protein, 0.85 mMCsA and 2 mg/ml oligomycin
plus 1 mM ADP were added to the reaction medium
2 min prior to Ca2C addition. In CsA plus TAM
condition, CsA was added after mitochondria energiza-
tion.
2.10. Mitochondrial GSH content
GSH was determined with fluorescence detection
after reaction of the supernatant of the H3PO4/EDTA–
NaH2PO4 deproteinized mitochondria solution with o-
phthalaldehyde (OPT), pH 8.0, according to Hissin and
Hilf (1976). In brief, at the end of the DJm experiments,
500 ml of each mitochondrial suspension were rapidly
centrifuged at 7000 rpm for 5 min. The pellets resus-
pended with 1.5 ml phosphate buffer (100 mM NaH2-
PO4, 5 mM EDTA, pH 8.0) and 500 ml H3PO4 4.5%
were centrifuged at 50,000 rpm (Beckman, TL-100
Ultracentrifuge) for 30 min. The supernatant (100 ml)
was added to 1.8 ml phosphate buffer and 100 ml OPT.
After thorough mixing and incubation at room temper-
ature for 15 min, the solution was transferred to a quartz
cuvette and the fluorescence was measured at 420 nm.
The GSH content was determined from comparisons
with a linear glutathione standard curve.
2.11. Mitochondrial thiol oxidation
A variation of Ellman’s method was used to de-
termine the mitochondrial content in protein thiol
groups (Riddles et al., 1983). At the end of the DJm
experiments, 750 ml of each mitochondrial suspension
were frozen and thawed three times and, then, 750 ml of
sulphosalicilic acid 4% were added. The samples were
submitted to centrifugation at 30,000 rpm (Beckman,
TL-100 Ultracentrifuge) for 10 min at 4 C. The
supernatant was removed and the pellet was suspended
in 1.5 ml of phosphate buffer 100 mM, pH 8. The
suspension was sonicated and diluted to 2.6 ml in
phosphate buffer medium containing 385 mM 5,5#di-
thio-bis-(2-nitobenzoic acid). After 10 min of reaction,
the absorption was measured at 412 nm and the results
expressed as percentage of control.
2.12. Statistical analysis
Results are presented as mean (% of control/
peroxidation)G SEM of the indicated number of
experiments. Statistical significance was determinedusing the one-way ANOVA test for multiple compar-
isons, followed by the post hoc Tukey–Kramer test.
3. Results
3.1. Effect of TAM on brain mitochondria respiration
Respiratory control ratio (RCR) is the ratio between
mitochondrial respiration states 3 (consumption of
oxygen in the presence of substrate and ADP) and 4
(consumption of oxygen after ADP has been consumed).
Although 15 nmol TAM/mg protein did not affect
RCR, 30 and 70 nmol TAM/mg protein induced
a similar decrease (21.12G 1.91% and 23.69G 0.34%,
respectively) when compared with the control condition
(98.39G 2.37%Z 3.1G 0.07). However, 100 nmol
TAM/mg protein induced a decrease on RCR when
compared with the control condition (44.2G 0.05%) as
well as when compared with 15 (38.21G 4.08%), 30
(23.08G 1.86%) and 70 nmol TAM/mg protein
(20.51G 0.39%) conditions (Fig. 1). ADP/O ratio, an
indicator of oxidative phosphorylation efficiency, is
expressed by the ratio between the amount of
ADP added and the oxygen consumed during the
respiratory state 3. Compared with the control condi-
tion (99.57G 1.76%Z 1.73G 0.1 nmol ADP/nAtg O),
ADP/O ratio was significantly decreased by 70 (9.57G
0.24%) or 100 nmol TAM/mg protein (13.19G 0.23%)
(Fig. 1).
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Fig. 1. Effect of TAM on respiratory indexes (RCR and ADP/O ratio)
of brain mitochondria. Freshly isolated brain mitochondria (0.6 mg) in
1 ml of the standard medium were energized with 5 mM succinate.
Isolates were incubated with TAM for 2 min, at 30 C, before
mitochondria energization. Results are presented as meanG SEM of
six independent experiments. ***p! 0.001; **p! 0.01; *p! 0.05,
when compared with mitochondria in control condition.
###p! 0.001, when compared with mitochondria incubated with
15 nmol TAM/mg protein. $$$p! 0.001, when compared with
mitochondria incubated with 30 nmol TAM/mg protein.
&&p! 0.01, when compared with mitochondria incubated with
70 nmol TAM/mg protein.
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Effect of TAM on mitochondrial transmembrane potential (DJm), repolarization level, repolarization lag phase and ATP levels
Control
(n=6)
15 nmol
TAM/mg prot
(n=6)
30 nmol
TAM/mg prot
(n=6)
70 nmol
TAM/mg prot
(n=6)
100 nmol
TAM/mg prot
(n=6)
DJm 101.5 G 1.3% 99.5 G 1.1% 98.5 G 0.9% 95.2 G 1.4% 85.7 G 3.1% )))
,#,$$,&
Repolarization
level
104.9 G 1.7% 98.7 G 2.8% 97.1 G 1.2% 91.6 G 1.7% 68.5 G 7.0% ))),##,$$$,&
Repolarization
lag phase
99.8 G 0.9% 120.6 G 2.0% 131.4 G 8.7% 177.4 G 12.5% 406.2 G 64.9% ))),###,$$$,&&
ATP level 100.0 G 2.1% 126.4 G 11.2% 100.6 G 10.3% 94.7 G 10.0% 49.4 G 9.1% ))),###,$$,&
Freshly isolated brain mitochondria (0.6 mg) in 1 ml of the reaction medium supplemented with 3 mM TPP+ and 2 mM rotenone were energized with
5 mM succinate. Isolates were pre-incubated with TAM for 2 min, at 30 C, before mitochondria energization.
))) p!0.001, when compared with control condition (mitochondria without TAM); ### p! 0.001; ## p!0.01; # p!0.05, when compared
with mitochondria pre-incubated with 15 nmol TAM/mg protein; $$$ p!0.001; $$ p!0.01, when compared with mitochondria pre-incubated with
30 nmol TAM/mg protein. && p!0.01; & p!0.05, when compared with mitochondria pre-incubated with 70 nmol TAM/mg protein.3.2. Effect of TAM on brain mitochondrial transmem-
brane potential (DJm), repolarization level,
repolarization lag phase and ATP levels
The mitochondrial transmembrane potential (DJm)
is fundamental for the process of oxidative phosphor-
ylation, the conversion of ADP to ATP via ATP
synthase. Mitochondrial respiratory chain pumps HC
out of the mitochondrial matrix across the inner
mitochondrial membrane. The HC gradient originates
an electrochemical potential (Dp) resulting in a pH
(DpH) and a voltage gradient (DJm) across the
mitochondrial inner membrane. As shown in Table 1,only the presence of 100 nmol TAM/mg protein induced
a significant decrease on DJm and repolarization level
(capacity of mitochondria to re-establish the DJm, after
ADP phosphorylation) when compared with all the
other conditions tested (Table 1). The absolute values of
DJm and repolarization level from the control condi-
tion are 180.6G 1.73 mV and 160.1G 1.03 mV,
respectively. Accordingly, the repolarization lag phase
(time necessary for ADP phosphorylation) increased
significantly in the presence of the highest TAM
concentration tested. The absolute value of repolariza-
tion lag phase of control condition is 0.601G 0.04 min.
Fig. 2 shows representative traces of the effect of180
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Fig. 2. Representative traces of the effect of TAM on DJm, repolarization lag phase and repolarization level. Freshly isolated brain mitochondria
(0.6 mg) in 1 ml of the standard medium supplemented with 3 mMTPPC were energized with 5 mM succinate. Isolates were pre-incubated with TAM
for 2 min, at 30 C, before mitochondria energization.
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mg protein) of TAM on DJm, repolarization level and
repolarization lag phase.
The alterations observed in the oxidative phosphor-
ylation system were reflected on the energetic levels.
Table 1 shows that ATP levels decreased in the presence
of 100 nmol TAM/mg protein when compared with
control condition (50.57G 7.09%), 15 (76.97G 2.06%),
30 (51.17G 1.17%) and 70 nmol TAM/mg protein
condition (45.27G 0.87%).
3.3. Effect of TAM on hydrogen peroxide production
The production of H2O2 by mitochondria gives an
indication about the propensity of mitochondria to
originate and/or exacerbate oxidative stress. The maxi-
mal production of H2O2 was 21.4G 0.35 nmol/mg pro-
tein/15 min (102.0G 1.68%). We observed that all the
concentrations of TAM tested, 8.5 (55.70G 11.54%), 15
(35.29G 5.31%), 3 (23.76G 6.67%) and 70 nmol/mg
protein (11.62G 13.55%) reduced the production of
H2O2 when compared with the condition of maximal
production (Fig. 3).
3.4. Effect of TAM on lipid peroxidation: oxygen
consumption, TBARS formation and mitochondrial
transmembrane potential (DJm)
The oxygen consumption and TBARS assay were used
to determine the level of lipid peroxidation induced by
-
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Fig. 3. Effect of TAM on hydrogen peroxide production. Brain
mitochondria were incubated under standard conditions as described
in Section 2. Results are presented as meanG SEM of four independent
experiments. ***p! 0.001; **p! 0.01 when compared with basal
production of H2O2 (mitochondria in the absence of substrate).
###p! 0.001; ##p! 0.01, when compared with control condition
(mitochondria in the presence of substrate) @p! 0.05, when compared
with mitochondria incubated with 70 nmol TAM/mg protein.ADP/Fe2C. The maximal values of oxygen con-
sumption (Fig. 4A) and TBARS formation (Fig. 4B),
observed at 6 and 15 min of peroxidation, respectively,
were 172.8G 23.79 nmol O2/mg protein (100.0G 3.39%)
and 29.70G 1.27 nmol TBARS/mg protein (100.1G
4.28%). Concentrations of TAM above 8.5 nmol
TAM/mg reduce the extent of lipid peroxidation and this
protection was concentration-dependent (Fig. 4A, B).
The DJm is an important indicator of the mitochon-
drial membrane integrity. Fig. 4C shows that in the
presence of ADP/Fe2C, DJm was gradually lost
indicating an impairment of mitochondria. However,
the presence of 30 nmol TAM/mg protein avoided
membrane injury induced by ADP/Fe2C, which was
reflected by the maintenance of DJm (similar profile to
those of control condition).
3.5. Effect of TAM on the mitochondrial permeability
transition
3.5.1. DJm and calcium fluxes
The mitochondrial potential (DJm) drop is a typical
phenomenon that follows the induction of MPT. In
control conditions (Fig. 5A), the addition of 5 mM
succinate produced an DJm of 180 mV (negative
inside mitochondria), corresponding to the respiratory
state 4. Then, the first pulse of 20 nmol Ca2C/mg protein
led to a rapid depolarization (decrease of DJm)
followed by a small repolarization (recover of DJm).
The depolarization was due to the entry of Ca2C into
the electronegative mitochondrial matrix, followed by
the efflux of HC in an attempt to restore the DJm.
However, a second and third pulse of 20 nmol Ca2C/mg
protein led to a total depolarization of mitochondria.
Mitochondria can tolerate a certain amount of Ca2C,
but ultimately their capacity to adapt to Ca2C loads is
overwhelmed and mitochondria depolarize completely
due to a profound change in the inner membrane
permeability. Since the mitochondrial collapse of DJm,
associated to Ca2C overload, is related with MPT
opening, experiments were performed to further confirm
the induction of the MPT opening by studying the Ca2C
retention by energized mitochondria. Fig. 6 shows that
isolated brain mitochondria incubated with 50 nmol
Ca2C/mg protein in the presence of 2 mM phosphate
and energized with succinate, rapidly accumulate Ca2C
from the medium and, after a slow release of some of the
accumulated Ca2C, they were able to continue to
accumulate Ca2C, thus retaining part of the Ca2C
present in the medium. In the presence of 100 nmol
Ca2C/mg protein mitochondria retained a large portion
of this cation. However, in the presence of 150 nmol
Ca2C/mg protein mitochondria became unable to retain
the accumulated Ca2C due to MPT opening (Fig. 6).
These effects on calcium accumulation could be
prevented in the presence of 0.85 mM CsA and 1 mM
441P.I. Moreira et al. / Neuropharmacology 48 (2005) 435–447ADP plus 2 mg/ml oligomycin. Although both agents
contributed for a higher capacity of mitochondria to
accumulate Ca2C, the protection exerted by ADP plus
oligomycin was more effective than that exerted by CsA
(Fig. 6). The presence of 30 nmol TAM/mg protein
(2 min pre-incubation) exerted some protection against
mitochondrial membrane depolarization and calcium
release, by increasing the capacity of mitochondria to
accumulate Ca2C (Figs. 5B, 6B). Additionally, the
Control
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)presence of 0.85 mM cyclosporin A (CsA) (specific
inhibitor of MPT) added 2 min prior to Ca2C, afforded
a clear protection of mitochondria (Figs. 5C, 6).
However, in the presence of both agents, 30 nmol
TAM/mg protein and 0.85 mM CsA, the capacity of
mitochondria to accumulate Ca2C increased significant-
ly, mitochondria being more resistant to Ca2C addition
and, consequently, to MPT induction (Figs. 5D, 6B).
3.5.2. Effect of TAM on the mitochondrial GSH
content and protein thiol groups
Opening of MPT is stimulated by the alteration of
GSH and protein thiol redox status (–SH/ –SS–). We
observed that 60 nmol Ca2C/mg protein induced a sig-
nificant decrease on GSH content (28.7%G 0.29) when
compared with control condition (Fig. 7). The presence
of 30 nmol TAM/mg protein and/or 0.85 mM CsA
protect mitochondria against GSH release (Fig. 7).
Fig. 8 shows that 60 nmol Ca2C/mg protein induces
a small decrease of thiol groups. However, when
mitochondria were pre-incubated with 30 nmol TAM/
mg protein a significant increase on thiol groups
occurred (15.9G 1.5%) when compared with mitochon-
dria exposed to 60 nmol Ca2C/mg protein (Fig. 8). The
presence of 0.85 mM CsA or 30 nmol TAM/mg protein
plus 0.85 mM CsA protected against oxidation of thiol
groups (12.1G 0.45% and 6.06G 1.63%) when com-
pared to mitochondria exposed to 60 nmol Ca2C/mg
protein (Fig. 8).
4. Discussion
There is substantial evidence of impaired energy
metabolism and mitochondrial dysfunction in the
pathophysiology of chronic neurodegenerative disorders
and in acute neurodegeneration caused by ischemia/
reperfusion injury (Fiskum et al., 1999). Several
strategies have been developed in order to avoid or, at
least, reduce mitochondrial dysfunction. One of those
Fig. 4. Effect of TAM on lipid peroxidation: oxygen consumption (A),
TBARS formation (B) and DJm (C). Freshly isolated brain
mitochondria were incubated at 0.6 mg protein/ml under standard
conditions as described in Section 2. Isolates were pre-incubated with
TAM for 2 min, at 30 C, before the addition of ADP/Fe2C. Results
are presented as meanG SEM of four independent experiments. The
traces are typical of three independent experiments. (4A)
***p! 0.001; *p! 0.05 when compared with 3 min of peroxidation
condition. ###p! 0.001; ##p! 0.01; #p! 0.05, when compared
with 4 min of peroxidation condition. $$$p! 0.001; $p! 0.05, when
compared with 5 min of peroxidation condition. &&&p! 0.001;
&&p! 0.01, when compared with 6 min of peroxidation condition.
(4B) ***p! 0.001; **p! 0.01; *p! 0.05 when compared with the
peroxidation condition. ###p! 0.001, when compared with the
control condition. $$p! 0.01, when compared with 8.5 nmol TAM/
mg protein condition. &p! 0.05, when compared with 15 nmol
TAM/mg protein condition. @p! 0.05, when compared with 30 nmol
TAM/mg protein condition.
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three experiments.strategies consists in the use of ‘‘protective’’ substances
such as antioxidants. It has been reported that TAM
and its more active metabolite OHTAM, due to their
high partition into membranes, induce multiple cellular
effects including antioxidant actions (Wiseman et al.,
1990; Custo´dio et al., 1993, 1994) being strong intra-
membraneous scavengers of peroxyl radicals (Custo´dio
et al., 1994).
However, and like other antioxidants, high TAM
concentrations may adversely affect mitochondrial
functions. We observed that TAM concentrations above
30 nmol/mg protein induced a slight decrease on RCR
(Fig. 1), while ADP/O ratio was depressed with TAM
concentrations of 70 nmol/mg protein (Fig. 1). However,
the oxidative phosphorylation capacity was affected
only for TAM concentrations equal or higher than
100 nmol/mg protein (Table 1). Recently Hoyt et al.
(2000) reported that high concentrations of TAM cause
mitochondrial depolarization and are neurotoxic for
primary neuronal culture. Tuquet et al. (2000) observed
that increasing concentrations of TAM act as both an
uncoupling agent and a powerful inhibitor of electron
transport in liver mitochondria. Recently, Cardoso et al.
(2001, 2002b) reported that TAM and OHTAM de-
crease, in a concentration-dependent way, the RCR andADP/O ratio of liver mitochondria. In the same studies,
they observed that 20 nmol TAM/mg protein affects the
phosphorylation efficiency of liver mitochondria. The
authors also observed that the partial collapse on DJm
and the decrease on ADP phosphorylation parallel the
increase on state 4 respiration indicating an uncoupling
effect of these drugs on the oxidative phosphorylation
system (Cardoso et al., 2001, 2002b). This uncoupling
effect is due to a slight permeabilization to protons of the
inner mitochondrial membrane (Cardoso et al., 2002b).
Comparing the data from this study with those of
Cardoso et al. (2001, 2002b), it is clear that liver
mitochondria are more susceptible to TAM than brain
mitochondria since doses that do not affect brain are
already deleterious to liver mitochondria. The existence
of tissue-specific differences in mitochondria properties
has been previously described (Moreira et al., 2002). The
isolation procedure used in this study does not allow
separation of mitochondria from different cell types
meaning that ‘‘total’’ brain mitochondria could ‘‘hide’’
the response of a more vulnerable cell population.
However, we must keep in mind that in the brain,
a highly interconnected structure, the individual cells do
not react simply as individuals when oxidative or toxic
agents injure them. The different cell populations
443P.I. Moreira et al. / Neuropharmacology 48 (2005) 435–447interact with each other, even at some distance from the
site of the original toxin or injury. This means that
simply looking at how an individual cell population is
affected will not allow understanding how some cells
survive better than we could expect. We need to look at
how cells communicate with each other and how they
may help each other to survive. A more appropriate level
of description is to consider cooperative phenomena at
the population level.
We also observed that TAM has a powerful antiox-
idant capacity, protecting brain mitochondria against
H2O2 production and ADP/Fe
2C-induced lipid perox-
idation. H2O2 is a stable, uncharged and freely diffusible
reactive oxygen specie. The action of this molecule
includes the oxidation of proteins and lipids, DNA
strand breakage and base modification. Mitochondria
are the major source of H2O2 production (Cadenas and
Davies, 2000) and, at the same time, are also the targets
of many of the detrimental effects of this reactive
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uptake and release of sequestered Ca2C by mitochondria were
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experiments.molecule. Fig. 3 shows that TAM has a potent
concentration-dependent capacity to prevent H2O2 pro-
duction. This capacity of TAM could be extremely
important in terms of brain disorders such as Alzheim-
er’s disease. Of particular relevance to the role of H2O2
in Alzheimer’s disease is the observation that amyloid
b-peptide, which is a central element in this pathology
(Hardy and Higgins, 1992), can itself generate H2O2
(Huang et al., 1999; Brzyska et al., 2001). A study from
O’Neill et al. (2004) showed that raloxifene (estrogen
receptor modulator) at low concentrations (50 ng/ml)
induces a significant neuroprotection against b-amyloid-,
H2O2- and glutamate-induced toxicity. However, the
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Fig. 8. Effect of TAM on mitochondrial protein thiol groups
oxidation. Freshly isolated brain mitochondria (0.6 mg) in 1 ml of
the standard medium were energized with 5 mM succinate. Isolates
were pre-incubated with TAM and/or CsA for 2 min, at 30 C, before
mitochondria energization. Results are presented as meanG SEM of
six independent experiments. 60 nmol Ca2C/mg protein was added
after mitochondria energization. #p! 0.05, when compared with
mitochondria exposed to 60 nmol Ca2C/mg protein.
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agonist action in the absence of 17 b-estradiol whereas in
its presence raloxifene exerted a mixed estrogen agonist–
antagonist effect. Similarly, Lei et al. (2003) found that
estrogen and raloxifene can influence glial-mediated
inflammatory pathways and possibly protect against
age- and disease-related neuropathology.
Our results also show that TAM protects against
lipid peroxidation (Fig. 4). It has been described that
OHTAM, the principal metabolite of TAM, is a scaven-
ger of peroxyl radicals in several cells and systems.
OHTAM inhibits lipid peroxidation in sarcoplasmic
reticulum membranes (Custo´dio et al., 1994), Fe2C-
ascorbate-induced lipid peroxidation in rat liver micro-
somes (Wiseman et al., 1990) and ADP/Fe2C-induced
oxidation in brain mitochondria (Moreira et al.,
2004). Furthermore, the ability of TAM and OHTAM
to inhibit Cu2C-induced peroxidation of low-density
lipoprotein has been suggested to contribute to the
putative cardioprotective effects of these antiestrogens
(Wiseman et al., 1993). Dubey et al. (1999) demonstrat-
ed that estrogen and tamoxifen metabolites protect
smooth muscle cell membrane phospholipids against
peroxidation via a non-estrogen receptor-dependent
mechanism. There are, however, controversial reports
stating that TAM and OHTAM are associated with
intracellular oxidative stress (Duthie et al., 1995). These
discrepancies can be due to differences in the concen-
trations of TAM and OHTAM and/or experimental
models used. Indeed, some animal studies indicate the
existence of dose-related biphasic effects of estradiol
(Levesque and Di Paolo, 1993). Some effects are lost at
higher concentrations (Levesque and Di Paolo, 1993),
whereas others require high doses (Green et al., 1997).
These dose-related effects could be taken as an
advantage allowing the dissociation of the several
activities exerted by the compound in the target tissue.
It is possible that a similar picture occurs with
antiestrogen compounds.
Although TAM is extensively metabolised in the liver
(Fromson et al., 1973), it has been reported that in
humans equal amounts of TAM and its metabolites are
found in both normal brain tissue and cerebral
metastasis (Lien et al., 1991) suggesting that in living
organisms both TAM and OHTAM are involved in
neuroprotection. Moreover, owing to its high hydro-
phobic character and partition into biological mem-
branes (Custo´dio et al., 1991), the levels of TAM in
humans are 10- to 60-fold higher in tissues than in
plasma (1 mM) (Lien et al., 1991). Therefore, the
therapeutics with TAM may cause tissue concentrations
similar to those used in this study. However, we also
tested some concentrations higher than the physiolog-
ical/pharmacological tissue concentrations of TAM to
demonstrate that only extremely high doses of this drug
affect brain mitochondrial function.Since previous studies (Custo´dio et al., 1998; Hoyt
et al., 2000; Cardoso et al., 2001) demonstrated the
inhibitory effect of TAM on MPT induction, we decided
to evaluate the effect of 30 nmol TAM/mg protein on
Ca2C-induced MPT of isolated brain mitochondria.
This concentration of TAM was more effective against
MPT opening when compared with lower concentra-
tions of TAM tested (data not shown) and, as shown by
our data, is not toxic to brain mitochondria. The MPT
causes a non-selective permeabilization of the inner
mitochondrial membrane typically promoted by the
accumulation of excessive quantities of Ca2C ions and
stimulated by a variety of compounds or conditions
(Zoratti and Szabo, 1995). In this study, the classic
inductor Ca2C was used to induce MPT opening (Figs.
5, 6). Ca2C uptake was concentration-dependent, with
higher concentrations leading to a lower amount of
Ca2C being accumulated by mitochondria, indicating
a continuous cycling of Ca2C due to MPT induction.
The pore opening allows the equilibration of ions and
respiratory substrate between cytosol and mitochondrial
matrix leading to a reduction on DJm (Bernardi et al.,
1992) that is linked to depletion of GSH (Macho et al.,
1997). Indeed, mitochondrial pore induction is in-
timately associated with GSH and protein thiol redox
state (Le Quoc et al., 1976). Glutathione is the most
abundant antioxidant in the cell. Its protective action is
based on the oxidation of the thiol group of its cysteine
residue, resulting in the formation of oxidized glutathi-
one (GSSG); this is in turn, catalytically reduced back to
the thiol form GSH by glutathione reductase (Meister
and Anderson, 1983). Regeneration of GSH from GSSG
occurs in mitochondrial matrix. Continued regeneration
of GSH requires NADPH, which in turn requires
transhydrogenation of NADPC and NADH. In this
study, each experiment last for 4 min, a period of time
insufficient to induce any significant alteration in the
elements involved in GSH regeneration. Furthermore,
Custo´dio et al. (1998) showed that the loss of matrix
GSH is attributed to its release to the medium since no
GSSG was detected in any of the reactions and the total
GSH levels (intra and extramitochondrial) did not
change. So, the depletion of GSH was solely due to
the efflux from the permeabilized mitochondria, which
was prevented by cyclosporin A and tamoxifen. When
protein thiol groups from the inner mitochondrial
membrane are oxidized, the pore complex suffers
conformational changes resulting in a large non-
selective permeabilization of the mitochondrial mem-
brane (Kowaltowski et al., 1998). Accordingly, a de-
crease on GSH content (Fig. 7) and thiol groups (Fig. 8)
were observed in mitochondria exposed to Ca2C. The
effect of Ca2C on GSH content was more pronounced
than the oxidation of thiol groups probably because
a fraction of the GSH pool was used to prevent a drastic
oxidation of the thiol groups. This fact may be
445P.I. Moreira et al. / Neuropharmacology 48 (2005) 435–447interpreted as a rescue strategy in an attempt to inhibit
or, at least, delay MPT induction.
The presence of 30 nmol TAM/mg protein exerted
some protection against Ca2C-induced MPT opening
(Figs. 5B, 6B). Our data support the idea suggested by
Hoyt et al. (2000) that TAM may be an inhibitor of the
MPT in intact neurons. Furthermore, our results are
consistent with the observations of Morkuniene et al.
(2002) that OHTAM prevented calcium-induced loss of
cytochrome c from heart mitochondria. In our study,
CsA does not give a total protection against MPT
induction but increases the capacity of brain mitochon-
dria to accumulate Ca2C (Figs. 5C, 6). Simpson et al.
(2002) observed that TAM exerted a CsA-like action on
SH-SY5Y neuroblastoma mitochondria. Moreover,
Custo´dio et al. (1998) observed that 20 nmol TAM/mg
protein cause a total inhibition of Ca2C-induced de-
polarization of succinate-energized liver mitochondria
similar to that exerted by CsA. As referred above, due to
tissue-specific differences in mitochondria pore proper-
ties (Moreira et al., 2002) the ability of both agents,
TAM and CsA, to protect against MPT induction
differs significantly between different types of mitochon-
dria. The effect of CsA on the ability of brain
mitochondria to accumulate Ca2C was only moderate
when compared with the effects described for CsA on
muscle or liver mitochondria (Kristia´n et al., 2000;
Moreira et al., 2002). Similar effects of CsA were also
reported on cell lines (Murphy et al., 1996) and neuronal
primary cultures (Dubinsky and Levi, 1998). Another
study performed in a neuronal primary culture showed
that mitochondrial depolarization induced by glutamate
was partially inhibited by TAM (Hoyt et al., 2000).
TAM per se was capable of protecting against GSH
depletion (Fig. 7) and thiol oxidation (Fig. 8), being the
protection of thiol groups more pronounced than that
exerted by CsA. Custo´dio et al. (1998) also reported the
inhibitory effect of TAM on GSH release. However, the
most relevant finding was that 30 nmol TAM/mg
protein plus CsA exerted a higher protection against
MPT opening (Figs. 5D, 6B) when compared with the
protection exerted by each agent alone (Figs. 5B, C, 6).
These results indicate that the effects of both agents are
not additive, suggesting that they act at different places
on pore complex. The most plausible hypothesis
concerning MPT inhibition by CsA is that cyclophilin
D binding to the matrix side of the MPT favours its
opening and that CsA indirectly causes pore closure
through unbinding of cyclophilin D after formation of
the CsA–cyclophilin complex (Connern and Halestrap,
1996). In turn, MPT inhibition in brain mitochondria by
TAM may be due to its antioxidant properties since this
antiestrogen inhibits mitochondrial lipid peroxidation
and protects against mitochondrial H2O2 production,
thiol groups oxidation and GSH release.These results show that TAM can afford protection
against brain mitochondrial injury promoted by several
oxidative stress-related events, including the induction
of the mitochondrial permeability transition pore. Since
numerous neurodegenerative diseases are intimately
related with mitochondrial dysfunction, the protective
role of TAM seems worthy of further investigation to
explore the potential therapeutical applications of this
drug. However, the design of new therapeutical strate-
gies should take into account the potential hepatotox-
icity promoted by high doses of TAM.
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